Rankings
▼
Calendar
IRWD Q3 2021 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$603M
Q3 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$104M
+0.3% YoY
Gross Profit
$93M
89.5% margin
Operating Income
$65M
62.8% margin
Net Income
$56M
53.8% margin
EPS (Diluted)
$0.34
QoQ Revenue Growth
-0.3%
Cash Flow
Operating Cash Flow
$75M
Free Cash Flow
$75M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$499M
Stockholders' Equity
$580M
Cash & Equivalents
$576M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$104M
$103M
+0.3%
Gross Profit
$93M
$82M
+13.5%
Operating Income
$65M
$46M
+42.9%
Net Income
$56M
$34M
+62.2%
Revenue Segments
Collaborative arrangements revenue
$104M
99%
Collaborative arrangement, co-promotion agreements
$683,000
1%
Collaborative arrangement, other agreements
$547,000
1%
Collaborative arrangement, collaboration and license agreements
$219,000
0%
Geographic Segments
Canada and Mexico
$700,000
51%
North America
$668,000
49%
← FY 2021
All Quarters
Q4 2021 →